You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 130 No. 1, January 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Review
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (95)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Leukocyte Colony-Stimulating Factors

A Review of Associated Neutrophilic Dermatoses and Vasculitides

Maj Martin L. Johnson, MC; Col Ronald E. Grimwood, MC

Arch Dermatol. 1994;130(1):77-81.


Abstract

Background
Hematopoietic colony—stimulating factors are a diverse group of cytokines now commercially available through recombinant technology. The colonystimulating factors have proven utility in a wide spectrum of cytopenic states, and their use is now commonplace. Unlike many cytokines, the colony-stimulating factors are usually well tolerated. We present a dramatic case of pyoderma gangrenosum arising during granulocyte colony—stimulating factor therapy. Additionally, the relevant literature regarding cutaneous complications of colony-stimulating factor therapy is summarized.

Observations
Including our case, two reported patients developed pyoderma gangrenosum while under colony-stimulating factor therapy. Sweet's syndrome presented in an additional three patients, and necrotizing vasculitis was precipitated in three others. The eruptions consistently developed after 1 to 2 weeks of colonystimulating factor therapy and were apparently unrelated to the underlying systemic illness. Although most reactions developed de novo, three were superimposed on a preexisting inflammatory process.

Conclusions
Serious cutaneous adverse effects of colony-stimulating factors are distinctly rare but include neutrophilic dermatoses and necrotizing vasculitis. Upregulation of neutrophilic function and secondary release of cytokines may induce these complications. Early recognition and cessation of colony-stimulating factor therapy will limit the morbidity of these adverse events.

(Arch Dermatol. 1994;130:77-81)



Author Affiliations

USAF; USAF

From the Department of Dermatology, Wilford Hall Medical Center, Lackland Air Force Base, Tex.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Tender Erythematous Plaques in a Woman With Acute Myelogenous Leukemia--Diagnosis
Arch Dermatol 2006;142:235-240.
FULL TEXT  

Acute Pyoderma Gangrenosum Does Not Require Surgical Therapy
Tay et al.
Arch Fam Med 1998;7:377-380.
ABSTRACT | FULL TEXT  

Neutrophilic Dermatoses During Granulocytopenia
Aractingi et al.
Arch Dermatol 1995;131:1141-1145.
ABSTRACT  

Granulocyte-Macrophage Colony-Stimulating Factor in the Management of Severe Ecthyma Gangrenosum Related to Myelodysplastic Syndrome
Becherel et al.
Arch Dermatol 1995;131:892-894.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.